dexamethasone,lenalidomide,,bortezomib,topotecan,capecitabine,,paclitaxel,panitumumab,trastuzumab deruxtecan
gsk,takeda,daiichi sankyo,astrazeneca,amgen
['destinybreast04', 'paradigm', 'destiny,breast,4', 'destiny,breast,6', 'breast', 'determination', 'reecur', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'topotecan', 'sarcoma', 'mbc']
the #oncoalerttoptweet day 3 #asco22 the plenaries
tweet by 1. #destinybreast04: tdxd in low her2 mbc
2. #paradigm: pan +mfolfox6 in mcrc
3. #reecur: topotecan, cyclophos &amp; hd ifos in #sarcoma
4. #determination: rvd +/- asct + rev in myeloma 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??